Twist Bioscience Corp. (TWST)
140.80
-4.79
(-3.29%)
USD |
NASDAQ |
Aug 24, 16:00
143.50
+2.70
(+1.92%)
After-Hours: 06:42
Twist Bioscience Total Return Level : 140.80 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 140.80 |
| August 21, 2026 | 145.59 |
| August 20, 2026 | 136.33 |
| August 19, 2026 | 142.39 |
| August 18, 2026 | 116.10 |
| August 17, 2026 | 124.41 |
| August 14, 2026 | 118.57 |
| August 13, 2026 | 125.29 |
| August 12, 2026 | 125.21 |
| August 11, 2026 | 123.12 |
| August 10, 2026 | 124.88 |
| August 07, 2026 | 115.67 |
| August 06, 2026 | 109.08 |
| August 05, 2026 | 115.01 |
| August 04, 2026 | 99.44 |
| August 03, 2026 | 101.06 |
| July 31, 2026 | 91.55 |
| July 30, 2026 | 91.33 |
| July 29, 2026 | 85.47 |
| July 28, 2026 | 88.55 |
| July 27, 2026 | 86.54 |
| July 24, 2026 | 90.27 |
| July 23, 2026 | 92.44 |
| July 22, 2026 | 94.21 |
| July 21, 2026 | 95.86 |
| Date | Value |
|---|---|
| July 20, 2026 | 87.45 |
| July 17, 2026 | 93.85 |
| July 16, 2026 | 91.23 |
| July 15, 2026 | 92.61 |
| July 14, 2026 | 92.53 |
| July 13, 2026 | 90.35 |
| July 10, 2026 | 90.64 |
| July 09, 2026 | 93.67 |
| July 08, 2026 | 89.38 |
| July 07, 2026 | 91.03 |
| July 06, 2026 | 99.93 |
| July 02, 2026 | 99.24 |
| July 01, 2026 | 102.25 |
| June 30, 2026 | 102.88 |
| June 29, 2026 | 98.36 |
| June 26, 2026 | 99.84 |
| June 25, 2026 | 96.65 |
| June 24, 2026 | 91.35 |
| June 23, 2026 | 85.00 |
| June 22, 2026 | 85.17 |
| June 18, 2026 | 87.56 |
| June 17, 2026 | 82.87 |
| June 16, 2026 | 84.95 |
| June 15, 2026 | 80.79 |
| June 12, 2026 | 76.17 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Beam Therapeutics, Inc. | 28.33 |
| Prime Medicine, Inc. | 3.25 |
| Intellia Therapeutics, Inc. | 12.56 |
| 10X Genomics, Inc. | 63.80 |
| Generate Biomedicines, Inc. | 17.72 |